Abbott
AbbVie reconsiders Shire deal over tax laws
October 15, 2014Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax
AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …
Google partners with AbbVie on ageing
September 4, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google
Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …
AbbVie agrees to buy Shire for £32bn
July 18, 2014Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover
Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …
Mylan buys Abbott generics
July 15, 2014Manufacturing and Production, Sales and Marketing Abbott, Mylan, generics, new mylan
Abbott is to sell the portion of its branded generics business which operates in developed markets such as Europe to …
AbbVie a step closer to Shire takeover
July 14, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover
Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …
AbbVie makes fourth Shire offer
July 9, 2014Sales and Marketing AbbVie, Abbott, Shire, buyout, merger
The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …
AbbVie spells out Shire benefits
June 26, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger
AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …
AbbVie moves in on Shire with $46 billion bid
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger
AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
AbbVie hep C treatment fast-tracked
June 18, 2014Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi
The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …
AbbVie highlights treatment adherence
June 12, 2014Sales and Marketing ALIGN, AbbVie, Abbott, Crohn’s disease, TNF, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, treatment, ulcerative colitis
Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …
Abbott makes Latin America move
May 20, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging
Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …
Humira drives AbbVie again
April 28, 2014Sales and Marketing AbbVie, Abbott, Humira, RA
Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …
AbbVie drops EMA legal case after compromise
April 4, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials
AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …
Baxter to split in two next year
March 28, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro
Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …
AbbVie expands into Singapore
February 10, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology
AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …
Latest content
